Promotion gives CVS’ Bloom his due
Earlier this month, Mike Bloom, CVS’ chief merchant, got a promotion.
Opinion
There’s plenty of reason to be bullish about Rx
Everywhere community pharmacy operators turn these days there seems to be a new challenge. Over the weekend, chain drug stores and other prescription drug providers began to feel the fallout from the reduction in average wholesale prices mandated by the settlement of a class-action lawsuit.
Outsiders bring new thinking to industry
Chain drug retailing is changing more quickly and more dramatically than at any time in recent memory.
Retail Rx can’t afford to let its guard down
Retail pharmacy operators garnered a significant victory late last month when the state of Delaware agreed to rescind some of the cuts it had intended to make in reimbursements for prescriptions filled under the Medicaid program.
DeMino looks back on legendary career
When Len DeMino retired earlier this month after over 50 years of service to the profession of community pharmacy, he closed the door on the golden era of chain drug retailing, an era he helped define. When DeMino began his career in 1958 as a pharmacist for Washington, D.C.
An opportunity for NACDS to stand out
In a letter, Chain Drug Review‘s editor urges National Association of Chain Drug Stores chief executive Steve Anderson to tackle core issues for the association head on. Steve Anderson President and CEO NACDS 413 N. Lee St. Alexandria, Va.
For Rx, the time to act is now
Despite President Obama’s wish to have both chambers of Congress pass health care reform bills before the start of the August recess, it appeared almost certain that legislators would return home without acting.